Knowledge Distillery

This prospective cohort study enrolled 8 hospitalized COVID-19 patients and assessed them at subacute and chronic stage (after 6 months) with MoCA and…

This retrospective cohort study used the TriNetX electronic health records network, which has over 81 million patients’ data, to estimate the…

Evidence is urgently needed to support treatment decisions for children with multisystem inflammatory syndrome (MIS-C) associated with severe acute…

The assessment of real-world effectiveness of immunomodulatory medications for multisystem inflammatory syndrome in children (MIS-C) may guide…

The efficacy and safety of tofacitinib, a Janus kinase inhibitor, in patients who are hospitalized with coronavirus disease 2019 (COVID-19) pneumonia…

The major complication of COVID-19 is hypoxaemic respiratory failure from capillary leak and alveolar oedema. Experimental and early clinical data…

SARS-CoV-2 entry in human cells depends on angiotensin-converting enzyme 2, which can be upregulated by inhibitors of the renin–angiotensin system…

COVID-19 is associated with a prothrombotic state leading to adverse clinical outcomes. Whether therapeutic anticoagulation improves outcomes in…

Adolescence represents a crucial developmental period in shaping mental health trajectories. In this longitudinal, population-based study the authors…

Two mRNA vaccines, BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna), received Emergency Use Authorization from the US Food and Drug Administration.…

Venous thromboembolism (VTE) is a common complication of COVID-19. It is not well understood how hospitals have managed VTE prevention and the effect…

Myalgia, increased levels of creatine kinase, and persistent muscle weakness have been reported in patients with COVID-19. The objective of this…